Inovio pharmaceuticals stock.

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that it has made an equity grant to a newly hired employee under its 2022 Inducement Plan (the "Inducement Plan"). The …Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. About the company. INO fundamental analysis.U.S.: Nasdaq. Add to Watchlist. INO. About Inovio Pharmaceuticals Inc. Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious ...

Inovio Pharmaceuticals ' ( INO 4.66%) stock rose by more than 18.5% as of 2:30 p.m. ET on Wednesday after the company's Q2 earnings results broke the news of its plans to restructure its ...See why we are neutral on INO stock. ... Jun. 27, 2023 7:15 AM ET Inovio Pharmaceuticals, Inc. (INO) 11 Comments 3 Likes. Out of Ignorance. 7.05K Followers. Follow. Summary.

Jul 1, 2020 · What happened. Shares of Inovio Pharmaceuticals (INO-3.67%) were crashing 14.6% lower as of 10:55 a.m. EDT on Wednesday after falling as much as 20.7% earlier in the day. The drop stemmed from two ...

Jacqueline Shea, Ph.D. Dr. Jacqueline Shea has served as INOVIO’s President and Chief Executive Officer (CEO) since May 2022. She is responsible for establishing and leading INOVIO’s overall corporate strategy across its clinical programs and advancing its DNA medicines platform. Dr. Shea joined the Company in March 2019 as Chief Operating ...As of September 30, 2022, INOVIO had 249.5 million common shares outstanding and 268.7 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt. INOVIO reported ...Inovio Pharmaceuticals. Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate ...Nov 28, 2023 · 52-week High/Low: $2.07 / $0.32. 50/200 Day Moving Average: $0.407 / $0.664. This figure corresponds to the Average Price over the previous 50/200 days. For Inovio Pharmaceuticals stocks, the 50-day moving average is the support level today. For Inovio Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Nov 17, 2021 · It's been a rough 12 months for Inovio Pharmaceuticals (INO-3.67%).In the past year, shares of the company have declined by 35% while the S&P 500 has risen 30%. The main reason for this abysmal ...

The Action asserts claims on behalf of all Persons who purchased or otherwise acquired the common stock of Inovio between February 14, 2020 and August 10, 2020, inclusive. Plaintiffs' claims in the Action are set forth in the Second Amended Consolidated Class Action Complaint for Violation of the Federal Securities Laws filed on February 17 ...

3 Jan 2023 ... This could mean hype has come out of the stock because the bottom line is concerning investors. Generally speaking investors would consider ...Share Price as of November 9 4:00:00 PM EST Inovio Pharmaceuticals (INO) Stock Price Performance Inovio Pharmaceuticals (INO) Stock Key Data Summary Additional Data …ROBERT J. JUBA JR. “INOVIO’s team has extensive experience manufacturing DNA medicines and a proven track record of producing them at unprecedented speeds.”. “INOVIO’s CELLECTRA® intramuscular and intracellular smart devices have allowed us to deliver our optimized DNA plasmids directly into cells in the body to produce immune responses.Inovio's stock price has fluctuated widely since the start of 2020, trading at a high of $31.63 per share and a low of $1.38. It opened Friday at $2.51 per share.Inovio's stock price has fluctuated widely since the start of 2020, trading at a high of $31.63 per share and a low of $1.38. It opened Friday at $2.51 per share.ROBERT J. JUBA JR. “INOVIO’s team has extensive experience manufacturing DNA medicines and a proven track record of producing them at unprecedented speeds.”. “INOVIO’s CELLECTRA® intramuscular and intracellular smart devices have allowed us to deliver our optimized DNA plasmids directly into cells in the body to produce immune responses.Sep. 7, 2023, 08:14 AM. (RTTNews) - Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy ...Web

Inovio Pharmaceuticals, Inc. Common Stock (INO) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time Key Data Bid Price and Ask Price The bid & ask refers to the price that an...U.S.: Nasdaq. Add to Watchlist. INO. About Inovio Pharmaceuticals Inc. Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious ...Shares of Inovio Pharmaceuticals Inc. (INO) and Novavax Inc. (NVAX) took a hit on Wednesday as the companies failed to make it to the list of finalists for the Operation Warp Speed initiative. 2.WebJun 27, 2022 · Inovio Pharmaceuticals (INO-5.75%) stock rose slightly on an otherwise gloomy day for the wider market. Investors were cheered by the appointment of a new chief medical officer at their company. Shares of coronavirus vaccine developer Inovio Pharmaceuticals ( INO 1.39%) are down 11% to $8.50 apiece as of 10:30 a.m. EDT. The company reported second-quarter earnings after markets closed on ...Web

On March 1, Inovio Pharmaceuticals will release figures for the most recent quarter. Wall Street analysts predict losses per share of $0.168. Watch Inovio Pharmaceuticals stock price in real-time ...

While many coronavirus stocks soared to record highs over the past year, shares of Inovio Pharmaceuticals ( INO -5.75%) are down nearly 50% over the past 12 months. The company has not advanced ...WebTrack Inovio Pharmaceuticals Inc (INO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Inovio Pharmaceuticals is easily one of the most volatile stocks on the market right now. Even relatively mild news, such as its recent Q4 results, was enough to send the stock plunging 28%.Galectin Therapeutics Inc. 1.99. -0.13. -6.13%. Get Inovio Pharmaceuticals Inc (INO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.View Inovio Pharmaceuticals, Inc INO investment & stock information. Get the latest Inovio Pharmaceuticals, Inc INO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Nov 30, 2023 · Inovio Pharmaceuticals Stock Forecast. ... According to 1 stock analyst, the 12-month stock price forecast for INO stock stock is $2.00, which predicts an increase of ... INO stock trades near $10 currently and it is, in fact, down 27% from its pre-Covid high of around $14 in early March 2020 – before the coronavirus pandemic hit the world. INO stock has had a ...WebINVESTORS. & MEDIA. Loading... INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases.Second Quarter 2023 Financial Results. Cash, Cash Equivalents and Short-term Investments: As of June 30, 2023, cash, cash equivalents and short-term investments were $194.9 million compared to ...WebDec 1, 2023 · Stock analysis for Inovio Pharmaceuticals Inc (INO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Inovio Pharmaceuticals, Inc. stockholders' equity: Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 9 at December 31, 2022 and 2021

Get Inovio Pharmaceuticals Inc (INO.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Feb 2, 2022 · Inovio Pharmaceuticals. Market Cap. $111M. Today's Change. (2.77%) $0.01. Current Price. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ ... Find the latest Inovio Pharmaceuticals, Inc. (INO.MX) stock quote, history, news and other vital information to help you with your stock trading and investing.WebInovio Pharmaceuticals, Inc. Common Stock (INO) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Source: Kantar Media. Inovio Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time INO stock price.Stock analysis for Inovio Pharmaceuticals Inc (INO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis. PR Newswire Sep 7, 2023 12:00pm.Mar 1, 2023 · Inovio Pharmaceuticals, Inc. stockholders' equity: Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 9 at December 31, 2022 and 2021 Inovio Pharmaceuticals, Inc. stockholders' equity: Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 9 at December 31, 2022 and 2021Inovio Pharmaceuticals Inc (NASDAQ:INO) trade information Sporting 0.96% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on Friday, 12/01/23 when the INO stock price touched $0.40 or saw a rise of 6.08%.The proposed Settlement will create a cash settlement fund of $30,000,000 in cash and 7,000,000 shares of Inovio common stock (the "Settlement Stock") to be ...

Dec 1, 2023 · Nov. 01. MT. Maxim Lowers Price Target for Inovio Pharmaceuticals to $5 From $11, Maintains Buy Rating. 2022. MT. RBC Reinstates Inovio Pharmaceuticals at Sector Perform-Speculative Risk, Assigns $4 Price Target, Awaiting 'More Attractive' Entry Point, 'Clearer Path for Value Creation'. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 0.40, with a high estimate of 0.40 and a low estimate of 0.40. The ...In a major shakeup at Inovio Pharmaceuticals, company co-founder J. Joseph Kim is out as CEO. ... In early morning trading, Inovio's stock was down more than 31% at $1.72 per share.Instagram:https://instagram. best graphite etfquantam energyis biberk good insurancegsk pipeline 12 Feb 2014 ... Executives and guests of Inovio Pharmaceuticals, Inc. will visit the New York Stock Exchange (NYSE) on Wednesday, Feb 12, 2014. vanguard high yield bond etf1962 ferrari 11 Okt 2023 ... Inovio Pharmaceuticals (NASDAQ: INO) stock is up 50% on news from the FDA about the company's lead candidate. INO stock jumped on the news ... kroger and publix See Inovio Pharmaceuticals, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Inovio Pharmaceuticals, Inc. INO NASDAQ. INO NASDAQ. INO NASDAQ. INO NASDAQ. Market closed Market closed. No trades. See on Supercharts. Overview News Ideas Financials …WebInovio Pharmaceuticals Inc (INO) stock is trading at $0.86 as of 10:19 AM on Tuesday, Mar 28, a drop of -$0.05, or -5.9% from the previous closing price of $0.91. The stock has traded between $0.79 and $0.91 so far today. Volume today is less active than usual.